Funded Tech Companies
Asklepios BioPharmaceutical
Headquartered in Research Triangle Park, Asklepios BioPharmaceutical was bought by Bayer AG.
Company Overview
Company Name
Asklepios BioPharmaceutical
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
20 T.W. Alexander 110
Research Triangle Park, NC 27709
USA
Research Triangle Park, NC 27709
USA
Phone
Website
Email Address
Company Background Information
Overview
Asklepios BioPharmaceutical, Inc. (AskBio) is a privately held AAV gene therapy based company founded in 2001 to advance the work of Dr. Richard Jude Samulski, former Director of the Gene Therapy Center at the University of North Carolina (UNC) from the lab into the clinic. Dr. Samulski was the first to clone AAV for therapeutic purposes.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/26/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sheila Mikhail
Chief Medical Officer
Martin Childers
Chief Operating Officer
Robert King
Chief Scientific Officer
Philippe Moullier
Chief Technical Officer
Josh Grieger
Co-Founder
Richard Samulski
VP - Regulatory Affairs
Diane Balderson
Company Investors
- TPG Capital (John Schilling)
- Vida Ventures (Fred Cohen)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs